4
Changes in Ownership
PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-24-024667
Options or other derivatives
- CEO acquired 0 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Pershing Edward CEO | 2024-06-20 | Grant or award · 8% Unsecured Convertible Promissory Note | +0 | D | |||
Loading xslF345X05/ownership.xml…